Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and nutraceutical products, announced today that it is in the final stages of advanced due diligence for implementing Blockchain technology for payment processing. The company has been exploring this option for several months and is working closely with an industry-
specific advisory group in designing and implementing a commercialization strategy.
The Company’s online sales platform has seen exponential growth since its launch and with the introduction of a digital currency payment system, Isodiol anticipates its international footprint will increase significantly. This platform will reduce processing fees incurred by the Company as well as reduce risks associated with foreign exchange fluctuations.
“There are tremendous benefits to implementing Blockchain technology and we look forward to improving our overall customer experience by providing alternative payment options,” said Marcos Agramont, CEO of Isodiol International “As Blockchain technology evolves, Isodiol has every intention to continue improving its payment processing options.”
The Company anticipates providing additional information on this rollout in the coming weeks.
For more information on Isodiol, please visit
Source: Technical 420